NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic
Press Release
Read More
NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients
Press Release
Read More
NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference
Press Release
Read More